Limit Opioids for Acute Decrease Risk of Long-Term Use

You'll see stronger efforts to limit opioid use for pain...due to new FDA warnings and CDC prescribing guidelines.

Product labeling will contain new, FDA-required boxed warnings for SHORT-acting opioids about abuse, overdose, etc...similar to those already in place for LONG-acting opioids.

CDC also now recommends limiting opioid doses and durations. This will lead to changes with insurers, quality measures, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote